This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Dividend Stocks That Want to Pay You More Cash

Mead Johnson

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Mead Johnson (MJN - Get Report) has seen some ups and downs in the last few months, but that hasn't stopped the pediatric nutrition firm from generating gains of more than 15% this year. Coupled with a 15.38% dividend increase announced last Friday, MJN is well positioned to continue outperforming the broad market in 2012.

Towards the end of 2011, there was some concern that the firm's Enfamil formula could have been tainted with Cronobacter bacteria, leading to the death of one child and the hospitalization of others. But the FDA and CDC effectively cleared the firm after not finding any traces of the bacteria in their testing. Although that risk knocked shares significantly lower to start the year, MJN has made up lost ground and then some in the last couple of months.

Customer stickiness, government subsidies, and international growth are three key reasons why Mead Johnson looks attractive right now. With each of those tailwinds working to propel shares, the firm's performance thus far could certainly have further to run.

While a 1.51% yield hardly makes MJN a core income holding, the payout is a nice added for investors who were willing to buy shares on other merits.

Mead Johnson is one of the top holdings at Daniel Loeb's Third Point, and it also shows up in Renaissance Technologies' portfolio as of the most recently reported quarter.

5 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AMAT $16.81 0.00%
CL $66.19 0.00%
GD $134.20 0.00%
MJN $71.94 0.00%
QCOM $44.02 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs